Get an email when this journal's indexing changes
Added to or removed from Scopus, Web of Science, ABDC, DOAJ, FT50, UT Dallas or ONOS. One confirmation click; unsubscribe anytime.
Neuroimmunology Reports is Scopus-indexed (Q4, CiteScore 0.9). Published by Elsevier B.V..
Checked against the index lists dated .
ISSN 2667-257XVerify ISSN ↗
Publisher: Elsevier B.V.
Cost to publish: About US$2,120 to publish open access (publisher list price, via OpenAlex) — subscription publishing may be free
| Subject area | Rank | Pctile | Q |
|---|---|---|---|
| Neurology (clinical) | 330 / 403 | 18th | Q4 |
| Immunology and Allergy | 200 / 234 | 14th | Q4 |
| Neuroscience (all) | 103 / 112 | 8th | Q4 |
Not listed in: Web of Science, DOAJ, ABDC, ABS / AJG, FT50, UT Dallas, ONOS (subscription), ONOS (APC covered)
Yes — actively indexed in Scopus, coverage 2021–present, best quartile Q4, CiteScore 0.9.
Neuroimmunology Reports is Q4 in Neurology (clinical) (rank 330 of 403), Q4 in Immunology and Allergy (rank 200 of 234) and Q4 in Neuroscience (all) (rank 103 of 112), by CiteScore 2025.
Neuroimmunology Reports is not in the Web of Science Core Collection (SCIE, SSCI, AHCI or ESCI), so Clarivate publishes no Journal Impact Factor for it. Its Scopus CiteScore is 0.9, quartile Q4, 18th percentile. Any "impact factor" quoted elsewhere is not the Clarivate metric. Its SCImago Journal Rank (SJR, a free Scopus-based metric) is 0.200, quartile Q4, with an H-index of 6.
The publisher lists an article processing charge of about US$2,120 for open access (source: OpenAlex). Many journals also publish by the subscription route at no cost to the author, so confirm on the journal's own website.
Neuroimmunology Reports is published by Elsevier B.V. Its ISSN is 2667-257X.
No — it is not currently in the Web of Science core collections (SCIE, SSCI, AHCI or ESCI).
No — it is not registered as an open-access journal in DOAJ or Scopus.
Neuroimmunology Reports has an h-index of 9 and a 2-year mean of 0.64 citations per paper (OpenAlex). Its Scopus CiteScore is 0.9, quartile Q4. On 2-year citations it ranks #306 of 403 Scopus journals in Neurology (clinical).
Neuroimmunology Reports published 31 papers in 2025; its busiest recent year was 2022 with 107. 2026* is the year so far.
h-index, i10-index and 2-year mean citedness are open, licence-clear metrics from OpenAlex — not a proprietary impact factor. The subject rank counts only journals that OpenAlex has a figure for; it is not a Scopus or Clarivate ranking. Updated 2026-10-14.
In its latest 97 research articles (2023–2026), authors are most often from United States (35.1%), China (5.7%) and Japan (5.2%).
Countries are counted fractionally, so a paper by authors from two countries counts half to each.
Scopus status: Active. 5 retracted papers are recorded (17.6 per 1,000 papers). The Problematic Paper Screener flags none of its papers. These are indicators to check, not findings against the journal.
Retractions from OpenAlex; flags from the Problematic Paper Screener (Cabanac, Labbé & Magazinov, CC BY), 2026-09-21 export. A flag marks a paper for a closer look; it is not a finding against the journal.
Index data is curated from public sources (Scopus, Web of Science, ABDC, FT50, UT Dallas, DOAJ). CiteScore and quartiles reflect the latest available Scopus release. Always verify a journal's current status on its official source before submitting.
Comments load as you scroll here.